← FDA Drug Approvals (Drugs@FDA)
LITHIUM CITRATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2023-08-14
Drug application
- FDA Application #
ANDA218036- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LITHIUM CITRATE
- Generic name
- LITHIUM
- Active ingredients
- LITHIUM CITRATE
- Dosage form
- SYRUP
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- RUBICON RESEARCH
- Manufacturer
- Advagen Pharma Ltd
- First approval
- 2023-08-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown